ATYPICAL CHRONIC MYELOID LEUKEMIA

Clinical trials for ATYPICAL CHRONIC MYELOID LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new ATYPICAL CHRONIC MYELOID LEUKEMIA trials appear

Sign up with your email to follow new studies for ATYPICAL CHRONIC MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 2

New hope for rare blood cancers? immune therapy trial seeks to tame disease

Disease control Not yet recruiting

This study is testing a long-acting immune therapy drug called ropeginterferon alfa-2b for adults with rare, overlapping blood cancers like chronic myelomonocytic leukemia (CMML). The main goals are to find a safe and effective dose and to see if the drug can control the disease …

Matched conditions: ATYPICAL CHRONIC MYELOID LEUKEMIA

Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

ATYPICAL CHRONIC MYELOID LEUKEMIA

Get alerted when new ATYPICAL CHRONIC MYELOID LEUKEMIA trials appear

New hope for rare blood cancers? immune therapy trial seeks to tame disease